Is There an Interest to Use Deuteron Beams to Produce Non-Conventional Radionuclides? by Cyrille Alliot et al.
REVIEWS IN MEDICINE
published: 11 May 2015
doi: 10.3389/fmed.2015.00031
Edited by:
Anil Kumar Mishra,
Defence Research Development
Organization, India
Reviewed by:
Puja Panwar Hazari,
Institute of Nuclear Medicine and
Allied Sciences (INMAS), India
Maria Mathew D’Souza,
Institute of Nuclear Medicine and
Allied Sciences (INMAS), India
*Correspondence:
Ferid Haddad,
GIP ARRONAX, 1 rue Aronnax, CS
10112, Saint-Herblain Cedex 44817,
France
haddad@cyclotron-nantes.fr
Specialty section:
This article was submitted to Nuclear
Medicine, a section of the journal
Frontiers in Medicine
Received: 10 April 2015
Accepted: 27 April 2015
Published: 11 May 2015
Citation:
Alliot C, Audouin N, Barbet J,
Bonraisin A-C, Bossé V, Bourdeau C,
Bourgeois M, Duchemin C, Guertin A,
Haddad F, Huclier-Markai S,
Kerdjoudj R, Laizé J, Métivier V,
Michel N, Mokili M, Pageau M and
Vidal A (2015) Is there an interest to
use deuteron beams to produce
non-conventional radionuclides?
Front. Med. 2:31.
doi: 10.3389/fmed.2015.00031
Is there an interest to use deuteron
beams to produce non-conventional
radionuclides?
Cyrille Alliot1,2, Nadia Audouin1, Jacques Barbet1,2, Anne-Cecile Bonraisin1,
Valérie Bossé1,2, Cécile Bourdeau1, Mickael Bourgeois1,2, Charlotte Duchemin3,
Arnaud Guertin3, Ferid Haddad1,3*, Sandrine Huclier-Markai3, Rabah Kerdjoudj3,
Johan Laizé1, Vincent Métivier 3, Nathalie Michel1,3, Marcel Mokili1,3, Mickael Pageau1 and
Aurélien Vidal1
1 GIP Arronax, Saint-Herblain, France, 2 CRCNA, CNRS, INSERM, Université de Nantes, Nantes, France, 3 Subatech, EMN-
IN2P3/CNRS, Université de Nantes, Nantes, France
With the recent interest on the theranostic approach, there has been a renewed interest
for alternative radionuclides in nuclear medicine. They can be produced using common
production routes, i.e., using protons accelerated by biomedical cyclotrons or neutrons
produced in research reactors. However, in some cases, it can be more valuable to
use deuterons as projectiles. In the case of Cu-64, smaller quantities of the expensive
target material, Ni-64, are used with deuterons as compared with protons for the same
produced activity. For the Sc-44m/Sc-44g generator, deuterons afford a higher Sc-44m
production yield than with protons. Finally, in the case of Re-186g, deuterons lead to a
production yield five times higher than protons. These three examples show that it is of
interest to consider not only protons or neutrons but also deuterons to produce alternative
radionuclides.
Keywords: radionuclide production, deuteron, theranostic, copper-64, rhenium-186, scandium-44
Introduction
Radionuclides are used in nuclear medicine for both imaging and/or therapy (1). For the last two
decades, positron emission tomography (PET) and molecular radiotherapy have developed rapidly.
Fluorine-18 and especially F-18 fluorodeoxyglucose, FDG, is themain driving force for PET imaging
(1) whereas yttrium-90 and lutetium-177 have shown promising clinical results for antibody or
peptide labeling.
Recently, the concept of theranostics, which is a treatment strategy that combines therapy and
diagnosis, has emerged. By doing imaging prior to the treatment, it is possible to select patients that
will respond to a given treatment, to make dosimetry prior to therapy, and to define the activity to
inject. Treatment efficacy may also be assessed. To achieve this aim, several types of isotopes can
be selected: radionuclides that possess radiations for both imaging and therapy, as for example Sn-
117m, pairs of radionuclide of the same element, like I-124 (for imaging) and I-131(for treatment),
or radionuclides with comparable chemical properties like Tc-99m (for imaging) and Re-186g (for
treatment).
The theranostic approach has renewed the interest for unconventional radionuclides in nuclear
medicine andmany radioisotopes with different properties (half-life, beta energy, gamma emissions)
are under study for either imaging or therapeutic use. These isotopes are mostly produced using
biomedical cyclotrons, which usually accelerate low-energy protons, or nuclear reactors, depending
on the radiation of interest. In all cases, it is of great importance to get high-specific activity.
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The aim of this paper is to illustrate the interest of using
deuterons as projectiles to produce alternative radionuclides for
medical applications. For that purpose, three examples are pre-
sented. These examples have been chosen according to the fact
that actual productions have beenmade. After a description of the
Arronax facility, which produces two out of the three isotopes on
a regular basis, and intends, in the future, to explore the possibility
to produce the last one, each isotope is presented. The added value
of using deuterons as projectiles is presented for each of them.
The Arronax Facility
The Cyclotron
The Accelerator for Research in Radiochemistry and Oncology
in Nantes Atlantique (Arronax) (2) cyclotron has turned into
operation in February 2011. It accelerates both positive (HH+,
He++) and negative ions (H , D ) up to 70MeV and delivers
up to 750µAe (two beams of 375µAe) of protons. This has been
tested successfully for 24 h in a row during the commissioning
phase. Arronax can deliver up to 70µAe of alpha-particles. The
capabilities of the cyclotron are summarized in Table 1.
Negative ions are extracted using the stripper foil technique.
This technique allows beam extraction with 99% efficiency within
a large range of incident energy by changing the radial position
of the foil. Here, the proton beam can be extracted from 30 to
70MeV. Arronax is equipped with two such devices diametrically
opposed. This gives the ability to deliver two beams with different
energies and intensities (up to 350µAe each for protons) at the
same time. Same feature can be made for the deuteron beam but
with a lower intensity (see Table 1).
Positive ions are extracted using an electromagnetic septum.
In this case, only one beam output is available at a fixed energy
of 68MeV for alpha-particles (extraction efficiency of 83%) and
17MeV for HH+ ions (extraction efficiency of 80%). This last
possibility provides a proton beam at lower energy than that of
H  particles without the use of a beam energy degrader.
The Surrounding Facility
Arronax can deliver a particle beam in six experimental vaults
named AX, A1, A2, P1, P2, and P3 (see Figure 1). Due to the
extraction method, which is different for negative and positive
ions, protons and deuterons are available in all experimental
vaults, whereas alpha-particles and HH+ generating protons are
available only in vaults A1, A2, and AX.
Vaults A1, A2, P2, and P3, which are dedicated to radionuclide
production, are equipped with irradiation stations and remote
pneumatic transfer systems (rabbit system) of the irradiatedmate-
rials from the beam lines into the hot cells. This system insures the
TABLE 1 | Characteristics of the beams available at Arronax.
Beam Accelerated
particles
Energy
range (MeV)
Intensity
(μAe)
Number of simultaneous
extracted beams
Protons H  30–70 <375 2
HH+ Fixed 17 <50 1
Deuterons D  15–35 <50 2
α-Particles He++ Fixed 68 <70 1
vacuum tightness in the beam lines and allows the connection to
a water cooling system during irradiation. It can handle different
types of targets depending on the desired radionuclide. We have
developed two different designs. The first one accommodates a
target tilted at 15° with respect to beam axis with one face of the
target placed in vacuum and the other one cooled with water. The
other type of rabbit can accommodate encapsulated targets placed
at 90° with respect to the beam axis, which are water cooled all
over their surface. A 4-fingers collimator is placed in front of the
target station to center the beam and to limit its diameter.
In vault P1, a high power accelerator-driven neutron source is
installed (3).
The largest vault, AX, is devoted to radiochemistry, physics, and
radiobiology experiments as well as advanced student training.
The beam line entering this vault can be sent in three different sub-
beam lines at the end of which experimental devices are placed.
One of the beam lines is directed to a pit providing a vertical beam,
which is of great interest for the irradiation of chemical solutions
and cells for radiolysis or radiobiology experiments. The two other
lines are currently used for physics and radiolysis experiments.
In addition, several laboratories (radiochemistry, biochem-
istry, hot cells, radiolabeling, chemical analysis, nuclear metrol-
ogy : : :) are available allowing radiopharmaceuticals development
and quality control of final products.
Deuteron Production of Non-Conventional
Radionuclides
To produce alternative isotopes, deuteron beams can, in some
cases, be more interesting than proton beams. Three examples are
presented below to illustrate this fact. All the nuclear data used
were extracted from the NUDAT database (4).
Scandium-44
Sc-44g has a half-life of 3.97 h. It decays through electron capture
in 5.73% of the cases and by β+ emission in 94.27% of the cases
with a mean kinetic energy of 632 keV. It can be used for PET
imaging and will be complementary to the shorter half-life 68Ga
(T1/2= 67.71min). It is possible to produce an excited state of Sc-
44 called Sc-44m (T1/2= 58 h), which decays to the ground state
by gamma emission (E
γ
= 271.24 keV, I
γ
= 86.7%). It has been
proven that when a molecule is labeled with Sc-44m, the Sc-44g
formed by its decay remains attached to the molecule (5). This
indicates that Sc-44m/Sc-44g may be used as an in vivo generator
to study long biological processes such as those associated to
labeled full antibodies.
Among the scandium isotopes, Sc-47 (β  emitter) is well suited
for use in targeted radionuclide therapy. There is then a potential
interest to use Sc-44 for dosimetry studies before using Sc-47 for
therapy, as a theranostic approach (6).
Finally, associated to Sc-44g decay, a high-energy gamma ray
at 1.157MeV with a high probability of occurrence (99.9%) is
emitted within nanoseconds. By measuring the incident direction
of this photon and the line of response of the 511 keV photons
resulting from the β+ decay, it is possible to get, on an event
by event basis, the emitter location in three dimensions as pro-
posed by Grignon et al. (7). With a Compton telescope using a
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FIGURE 1 | Schematic view of the ARRONAX cyclotron and its target vaults.
new generation of cameras based on a liquid xenon time projec-
tion chamber, a spatial resolution of 2.3mm has been estimated
with an injected activity of 0.5MBq for a Sc-44g point source
emitter (7).
Sc-44g and Sc-44m can be produced using enriched 44CaCO3
as target. The use of an enriched target maximizes the scandium
production and reduces the production of contaminants. Using
protons, production is achieved through the 44Ca(p,n) reaction.
This reaction has an energy threshold of 4.536MeV. One set of
cross-section data point exists (8) and can be used to estimate the
production yield. On Figure 2, the evolution of the production
cross-section of Sc-44 as a function of the proton incident energy
is presented. Data of Levkovskij (8) have been normalized by a
factor 0.8 due to a monitor problem (9). The maximum value of
the cross-section is obtained for 12MeV protons. The production
of the Sc-43, via the reaction (p,2n), starts at 14,458MeV. By
selecting proton incident energy below this value, it is possible
to prevent the production of Sc-43 although this isotope is an
attractive candidate for conventional PET imaging.
As stated before, Sc-44m is also produced during the irradia-
tion. The production cross-section of themetastable state changes
with the incident energy of the proton energy. The ratio of the pro-
duction cross-section of the metastable state over the ground state
has been measured by Sachdev et al. (10) for the (p,n) reaction
and its values are presented in Table 2. The measurements made
by Levkovskij (8) give values of the same order of magnitude. In
the energy range of interest, the Sc-44m will represent <15% of
FIGURE 2 | Sc-44g production cross section for proton and
deuteron-induced reaction on Ca-44. The symbols correspond to the
proton data of Levkovskij (8), the full line to TALYS calculation for protons and
dashed line to TALYS calculation for deuterons. TALYS 1.6 has been used for
these calculations.
the produced Sc-44g+ Sc44m atoms. It has to be kept in mind
that, experimentally, we have access to the activity and not to the
number of produced isotope. Due to the large difference in half
lives, activity ratio will bemuch smaller (divide by a factor of ~15).
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TABLE 2 | Evolution of the cross-section ratio as a function of the proton incident energy (10).
E (MeV) 6 9 12 15 18 21 24 30 40 50 60 72 85
σ(Sc-44m)/(σ(Sc-44g) 0.015 0.063 0.090 0.140 0.20 0.24 0.23 0.19 0.16 0.14 0.15 0.16 0.17
Another parameter that affects this ratio is the irradiation time.
The saturation is reached earlier for Sc-44g than Sc-44m.
An alternative production route is to use deuterons as pro-
jectiles through the 44Ca(d,2n) reaction, which has an energy
threshold equal to 6.964MeV. We did not find cross-section data
with deuterons in the literature and we have therefore chosen to
use the TALYS code version 1.6 (11) to estimate the production
yields in order to compare with the proton route. TALYS is a
computer program for simulation of nuclear reactions induced
by light projectiles on nuclei heavier than carbon. It integrates
many theoretical models that predict the behavior of various
observables, among which the production cross-sections, in the
energy range from 1 keV to 1000MeV. TALYS can work with a
limited number of input parameters: the type of projectile and its
incident energy, the target element and its atomic mass. Default
settings are assigned to each nuclearmodel and several parameters
can be modified to better describe the data. In this work, we used
the default settings.
Before using the code to obtain the (d,2n) cross-section values,
we have compared the experimental cross-section for the reaction
(p,n) measured by Levkovskij (8) with the values predicted by
TALYS. The data are presented as symbols on Figure 2 whereas
the TALYS values are presented as full lines on the same Figure.
A good agreement is found between the data and the code values
giving us confidence on the ability of this code to predict deuteron
cross-section values.
TALYS was then used to estimate the Sc-44g and Sc-44m pro-
duction cross-sections associated to the (d,2n) reaction on Ca-44.
On Figure 2, the dashed line corresponds to the Sc-44g cross-
section obtained with the TALYS code. We find that the produc-
tion cross-section maximum value with deuterons is comparable
to the proton one. The curve has a maximum a little lower in
amplitude but it is wider. Based on this curve, we see that we must
be in the energy range 10–20MeV to optimize the production of
Sc-44g with deuterons. This range is consistent with the available
deuteron energy on ARRONAX. In addition, production being
related to the integral of cross-section over energy, yield using
deuterons will be at least equal to that obtained with protons.
TALYS can also calculate the cross-section ratio of Sc-44m
over Sc-44g. The latter is presented as a function of the projectile
incident energy in Figure 3. TALYS calculations for protons and
deuterons are presented, respectively, as full line and dashed line.
From this figure, it is clear that the values obtained with deuterons
are larger than with protons. With deuterons, as much as three
times more Sc-44m can be expected as compared to protons.
The last point of interest, when comparing both production
routes, is related to the co-production of other isotopes. Using a
proton beam and a typical enriched target, only Sc-43 will have
an impact on the specific activity. The other produced isotopes
are stable or have short periods (less than minutes). Sc-43 amount
can be tuned by changing the proton incident energy. Below the
(p,2n) reaction threshold, no Sc-43 is produced.
FIGURE 3 | Ratio of the cross section associated to Sc-44m over the
cross-section associated to Sc-44g obtained from the TALYS code.
Using a deuteron beam and a typical enriched target, Ca-45
(T1/2= 162.61 days) will be produced via (d,p) reaction as well as
K-42 (T1/2= 12.321 h) via the (d,α) and K-43 (T1/2= 22.3h) via
the (d,2pn) reactions. These isotopes can be removed during the
chemical separation process but they will put some constraints
on it. The potassium isotopes produce scandium isotopes during
their decay that will have an impact on the specific activity of the
final product. It is then necessary to speed up the chemical process
in order to keep a high-specific activity.
At Arronax, small amounts of Sc-44g and Sc-44m have been
made using an irradiation station devoted to the production of
low activity batches (a few millicurie at maximum). With this
device, our target is placed in air, 6.6 cm downstream the beam
line output closed by a 75µm-thick kapton foil, which makes
the separation between the vacuum in the line and the air in
the vault. Each target is made of 500mg of 44CaCO3 pressed to
form an 18mm diameter pellet. To prevent any contamination
from the CaCO3 powder during irradiation, each target is placed
inside a frame made of 75µm kapton sheets on both sides. An
original chemistry has been developed using DGA chromato-
graphic column (5) from TrisKem International SAS (France).
After the chemistry, the expensive target material is recovered for
reprocessing.
The target is generally irradiated with deuterons of 16.4MeV
for 180min with a beam intensity around 300 nA. Scandium is
recovered as ScCl3. Typical activity for Sc-44g is 90MBq whereas
it is 1.8MBq for Sc-44m at the end of the chemistry step (around
4 h after EOB). The activity ratio is then equal to 2%, which is
coherent with TALYS calculations. If one except Sc-44g and Sc-
44m, all radionuclides are below the detection limit using our
HP-GE detector. Using an ICP-OES, themain stable contaminants
have been identified (Al, Fe, Zn, and Sc) and the total content
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FIGURE 4 | Production cross-section as a function of the projectile energy for Ni-64(p,n)Cu-64 (left) and Ni-64(d,2n)Cu-64 (right). Inspired by Ref. (17).
is lower than 1 ppm. These numbers show that deuterons can
be advantageously used to produce Sc-44m with a high-specific
activity.
Copper-64
Cu-64 has a half-life of 12.7004 h. It decays through electron
capture in 44.00% of the case, by β  in 38.48% with a maxi-
mum energy of 579.4 keV and finally by β+ emission in 17.52%
of the case with a maximum energy of 653 keV. Associated to
these emissions, there is a high-energy gamma ray at 1345.75 keV
with a low probability of occurrence (0.4749%). Considering the
emitted radiations, it can be used for both therapy and PET
imaging.
Several routes to produce Cu-64 have been reported in the
literature (12–16) among which the irradiation of enriched Ni-
64 with protons is the most often used. As most (p,n) reactions,
production cross-sections are high (see left plot on Figure 4).
Looking at the deuteron production route, it is found that the
maximumcross-section value for (d,2n) reaction is higher than for
(p,n), reaching 800mb at 14MeV. In addition, the curve evolves
more slowly around the maximum for (d,2n) in comparison to
(p,n) indicating a possible higher yield using deuterons (17). Using
a 16MeVdeuteron beam, it is possible to take full advantage of the
maximum cross-section. In this condition, theoretical production
yield has been calculated and compared with that obtained for a
12MeV proton beam (see Table 3). It shows that it is possible to
produce the same amount of Cu-64 in both cases with a target 25%
thinner using deuterons.
Differences in the co-produced contaminants exist between
the two production routes. On the one hand, the deuteron beam
produces Ni-65 (T1/2= 2.52 h) and stable Cu-65, which are not
created at all with the (p,n) reaction. On the other hand, less
Co-61 (T1/2= 1.65 h), which is created using proton via (p,α),
is produced with the deuteron reaction. When using a deuteron
beam, the production ofNi-65 (which decays toCu-65) andCu-65
will have an impact on the final specific activity. In order to have
some hints on their contributions, production yields have been
calculated for these isotopes and for Cu-63. When available, data
TABLE 3 | Cu-64 calculated yields for (p,n) and (d,2n) production routes.
Nuclear reaction Energy
range
(MeV)
Calculated
yield
(MBq/μAh)
Target
thickness
(μm)
Target
thickness
at 15°(μm)
Ni-64(p,n)Cu-64 12–9 228 120 31.05
Ni-64(d,2n)Cu-64 16–13 206 90 23.29
TABLE 4 | Direct and indirect productions of stable copper isotopes with a
deuteron beam on Ni-64.
Isotope Half-life Decay
product
Expected yield
(EOB) atoms
65Ni 2.52 h 65Cu 2.33 E+ 12
63Cu Stable – 2.07E+ 11
65Cu Stable – 6.1 E+ 11
65Ni decays during irradiation 3,3 E+ 11
64Cu 12.7 h Ni-64 1.31 E+ 13
have been taken from Kinsey et al. (4). Otherwise, we have used
the TALYS code with default parameters (11) to get cross-section
values. In Table 4, the calculated yield values are presented for a
1 h irradiation at 1µA.
The main stable copper contribution comes from the decay of
Ni-65 either during irradiation or after. The latter contribution
is strongly correlated to the time of the chemistry, the shorter
the separation is, the lower the contribution is, whereas the first
contribution increases with the irradiation time.
By considering the worst case in which all the Ni-65 has
decayed to Cu-65 when the chemistry is performed, we end
up with 3.8 atoms of Cu-64 for 1 atom of cold copper coming
for a 1 h irradiation. This corresponds to a specific activity of
7.22GBq/nMol as compared to the theoretical value for proton,
which is 9.13GBq/nMol. These numbers are far above what is
necessary for antibody labeling.
At our facility, the deuteron production route is used for Cu-64
production since Arronax is able to deliver this type of particles
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FIGURE 5 | Re-186g thick-target yield obtained from IAEA (20) data
with proton and deuteron and value determined from new
experimental data from Duchemin et al. (18). Symbols correspond to
values extracted from Hermann et al. (21) and Bonardi et al. (22).
(seeTable 3). A highly enriched (>99%)Ni-64 target electroplated
on a gold backing (99.99% purity) is used and an original chem-
istry has been developed using HBr on AG1X8 chromatographic
column. After the chemistry, the expensive target material is
recovered (recovery yield around 95%) for reprocessing.
A typical irradiation is carried out with 50µA deuterons beam
at 16MeV impinging a 10µm-thick target for 150min. Copper-64
is recovered as CuCl2 with a high-radioisotopic purity (>99.90%).
Using an ICP-OES, the main contaminants have been identified
as Ni, Cu, and Fe. On a routine basis, we produce 12GBq at the
end of bombardment. Production can be increased by using a
thicker target and increasing the irradiation duration. These num-
bers show that deuteron can be advantageously used to produce
Cu-64.
Rhenium-186g
Rhenium is aGroup 7 congener of Tc and therefore, inmany cases,
shares remarkably similar chemical behavior to Tc. Thus, Tc-99m
radiocomplexation knowledge can often be applied to rhenium
radionuclides. Re-186g is a β  emitter with a 137.157 keV γ
emission (branching ratio of 9.42%) that can be used for imaging
with SPECT. Its half-life is 3.7183 days. There is another β 
emitter isotope, 188Re, with a half-life of 0.7 days, which has a
155.032 keV γ emission suitable for imaging. In addition to their
different half lives, the mean β  energy of these two rhenium
isotopes is different: 347 and 763 keV for Re-186g and Re-188,
respectively. Because the chemistry of rhenium is close to that
of technetium, Tc-99m/Re-186g and Tc-99m/Re-188 can act as
potential theranostic pairs.
Re-188 can be obtained with a high-specific activity through a
W-188/Re-188 generator. Unfortunately, W-188 requires a dou-
ble neutron capture to be produced limiting its production to
high-flux nuclear reactor. Using nuclear reactors, it is not possible
to get high specific activity Re-186g. However, it is possible to use
accelerator to that purpose.
A promising production route is theW-186(d,2n). Its threshold
energy is equal to 3.6MeV. Deuteron with incident energy below
17.6MeV can be used to produce high-radionucleidic purity and
high-specific activity of Re-186g. Using deuterons as projectiles,
five times more Re-186g can be produced as compared to protons
as projectiles (seeFigure 5). Based on the calculation ofDuchemin
et al. (18), using an enriched W-186 target and an energy range
of 3.5–17.6MeV, a thick-target yield of 16.8MBq/µAh can be
obtained, which corresponds to 0.5 Ci (EOB) for 24 h irradia-
tion at 50µA. These numbers are in agreement with data from
Xiaodong et al. (19), which have reported the production of Re-
186g using a 16MeV deuteron beam via the (d,2n) reaction on
isotopically enrichedW-186metal powder. After chemical extrac-
tion and purification, no-carrier-added Re-186g saline solution
was obtained with a radionuclidic purity >99.9%. Main isotopic
impurities were Re-183 and Re-184g. The experimental thick-
target yield of Re-186g was determined to be ~529µCi/µAh.
These numbers show that deuteron is the projectile of choice to
produce high-specific activity of Re-186g.
Conclusion
Recently, the theranostic paradigm has renewed the interest
for unconventional radionuclides in nuclear medicine. Several
radioisotopes with different properties (half-life, beta energy,
gamma emissions) are under study for either imaging or ther-
apeutic use. In some cases, the use of deuterons as projectiles
to produce these radionuclides can be beneficial. Scandium-44
can be used for imaging. In addition to the ground state (Sc-
44g), there is a metastable state (Sc-44m) that can be used as
an in vivo Sc-44m/Sc-44g generator. When using deuterons to
produce these isotopes, one maximizes the production of the
metastable state as compared to the ground state, which is of
interest if one wants to use Sc-44 for imaging for long processes.
Another example is the production of Cu-64. It can be produced
from deuteron irradiation using the same target as for proton
but using a lower quantity of Ni-64, which is a very expensive
material. A theoretical study shows that the specific activity is a
little lower than in the case of proton irradiation but is still high
enough for medical applications. Finally, in the case of Re-186,
the use of deuterons is the only viable production route since
the production yield is five times higher than that obtained using
protons.
At the Arronax facility, we have access to deuteron beam at the
right energy anduse it already for routine production ofCu-64 and
Sc-44m/Sc-44g.Wehave started to look at theRe-186g production
with deuterons.
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